Rep. Rob Nosse, D-Portland is introducing legislation that goes farther than any other law in the nation to regulate prescription prices.
The story of one Oregon family, featured in the Portland Business Journal, stands out, Nosse said. When Les Rogers’ 4-year-old daughter was diagnosed with a rare seizure disorder, the family learned the treatment, a drug called Acthar, cost $35,000 per vial. The drug has been available since the 1950s, but when California-based Questcor Pharmaceuticals bought the rights to it, the company raised the price by 85,000 percent, from $45 a vial, Nosse noted.
Something clearly needs to be done about pharmaceutical companies' price-gouging, but that needs to happen at the federal level, not at the state level. Canada seems to have been able to control it.